Good afternoon - Many have been celebrating the news around a Covid 19 vaccine and it's reported success rate this week. Such great news. The Biotechnology industry has been making amazing progress on so many fronts this year, and very few are focusing on Covid 19 products. If you’re like many investors, you may be suffering from “virus fatigue.” I have to admit, the next article I write that doesn’t include the words “novel coronavirus” or “Covid 19” will be my first one since sometime in March. But that’s the nature of going through a global pandemic. It’s impossible to ignore the effect a virus can have on equities across all sectors. However, the global pandemic has generated both winners and losers. And some biotech stocks have shown elements of being both. Stocks like Moderna (NASDAQ:MRNA) have seen huge price swings on the whiff of being part of a solution. But that’s a tough way to invest, particularly if you’re a buy and hold investor. But does that mean you should completely bypass the biotech sector? Certainly not. Because while biotech stocks can be one of the most volatile sectors, they also offer the potential for some of the best rewards. And right now, several companies look primed to see their stock prices rise once investors turn their attention away from the race for a cure for Covid-19. And that day will come. It may not seem like it right now, but it will come. When it does, investors will find that diseases like cancer, muscular dystrophy, and rarer, but equally devastating conditions will still be around. And there will be companies working hard to get drugs and treatment on the market to fight them. We’ve identified seven companies, some small-cap and some large-cap, that are working diligently on drugs that can improve the quality of life for many people. And the stocks look undervalued right now. But they won’t stay that way forever. Because as much as we hear about a third wave, the virus will eventually be a memory. And when it is, investors will turn their attention to these stocks. So make sure you get there first. View the “7 Great Biotech Stocks That Don’t Depend on a Coronavirus Cure”
Matthew Paulson
MarketBeat.com | 
Tidak ada komentar:
Posting Komentar